Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
Zhuo Yuan, Dongke Yu, Tingting Gou, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 175931-175931
Open Access | Times Cited: 17

Showing 17 citing articles:

Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression
Lucas Fornari Laurindo, Jefferson Aparecido Dias, Adriano Cressoni Araújo, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 51
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
Cells (2024) Vol. 13, Iss. 17, pp. 1413-1413
Open Access | Times Cited: 10
Xiongshao Zhitong granules alleviate nitroglycerin-induced migraine by regulating the TRPV1-mediated NLRP3 inflammatory pathway in rats
Yuxi Wang, Yang Song, Xiaoyao Liu, et al.
Phytomedicine (2025), pp. 156754-156754
Closed Access | Times Cited: 1
Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors
Ye Tian, Xiaofang He, Ruping Li, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117874-117874
Closed Access | Times Cited: 6
Discovery of Potent, Specific, and Orally Available NLRP3 Inflammasome Inhibitors Based on Pyridazine Scaffolds for the Treatment of Septic Shock and Peritonitis
Zhiyuan Fu, Yangqin Duan, Heying Pei, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15711-15737
Closed Access | Times Cited: 5
Senoinflammation as the underlying mechanism of aging and its modulation by calorie restriction
Sang Gyun Noh, Hyun‐Woo Kim, Seungwoo Kim, et al.
Ageing Research Reviews (2024), pp. 102503-102503
Closed Access | Times Cited: 5
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li Wu, Xie Yong-Yan, Mu Jia-Xin, et al.
Brain Research (2025), pp. 149480-149480
Closed Access
Anthocyanin-Rich Fraction from Kum Akha Black Rice Attenuates NLRP3 Inflammasome-Driven Lung Inflammation In Vitro and In Vivo
Sonthaya Umsumarng, Warathit Semmarath, Punnida Arjsri, et al.
Nutrients (2025) Vol. 17, Iss. 7, pp. 1186-1186
Open Access
Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies
Ahmed M Abdelaziz
International Immunopharmacology (2025) Vol. 156, pp. 114692-114692
Closed Access
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
(2024)
Open Access | Times Cited: 3
RND3 modulates microglial polarization and alleviates neuroinflammation in Parkinson's disease by suppressing NLRP3 inflammasome activation
Wentao Hu, Menghan Wang, Guifang Sun, et al.
Experimental Cell Research (2024) Vol. 439, Iss. 1, pp. 114088-114088
Closed Access | Times Cited: 2
Renoprotective effect of rosmarinic acid by inhibition of indoxyl sulfate-induced renal interstitial fibrosis via the NLRP3 inflammasome signaling
Tung‐Wei Hung, Yi‐Hsien Hsieh, Hsiang‐Lin Lee, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112314-112314
Closed Access | Times Cited: 1
Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1184-1185
Closed Access
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
(2024)
Open Access
Synthesis, biological evaluation and molecular dynamics simulations of new sulfonylurea derivatives bearing biphenyl moieties as potential NLRP3 inhibitors
Xin Xiong, Ruifeng Zhang, Zhijian Min, et al.
Research on Chemical Intermediates (2024) Vol. 50, Iss. 12, pp. 5863-5883
Closed Access
Preventing NLRP3 inflammasome activation: Therapeutic atrategy and challenges in atopic dermatitis
Yiran Sun, Yangang Zhou, Tong Peng, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113696-113696
Closed Access
Development and validation of a method for screening NLRP3 inflammasome inhibitors on primary macrophages from C57bl/6j mice
Roman D. Danilov, E. V. Sokolova, Ekaterina Zakharova, et al.
Journal of Volgograd State Medical University (2024) Vol. 21, Iss. 4, pp. 51-55
Open Access
Page 1

Scroll to top